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doi:10.1016/j.ejvs.2009.10.015Abstract Objectives: This study aims to evaluate the results and complications of surgical
arterial revascularisation of the upper limb for treatment of chronic ischaemia using infrabra-
chial bypass. Results of limb salvage and follow-up with graft patency are analysed.
Design: This study is a retrospective analysis of 23 patients affected by chronic upper limb
ischaemia and treated by surgical bypass.
Materials and methods: We retrospectively analysed 23 patients with upper limb ischaemia
treated between January 1998 and January 2008, by means of bypass graft revascularisation.
After surgical revascularisation, eight patients (35%) with digital gangrene underwent minor
amputations during the same surgical session, or within the following few days. Postopera-
tively, patients were followed up at regular intervals of 1, 3 and 6 months, and every 6 months
thereafter, both clinically and with a duplex ultrasound scan.
Results: The mean 34 months’ follow-up was 96% complete. Life table analysis revealed
a primary patency of 82.6% and secondary patency of 91.3%. Limb salvage was 100%.
During the follow-up period, four patients sustained graft occlusion and, of these, two
underwent re-do revascularisation with success.
Conclusions: We believe upper limb bypass surgery represents a valid treatment in this clinical
setting, both for limb salvage and for relief of symptoms.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ento Cardiovascolare e Tor-
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ty for Vascular Surgery. PublisheIntroduction
Arterial reconstruction for the treatment of chronic upper
limb ischaemia is infrequently performed in a vascular
surgical practice. Upper limb ischaemia requiring surgical
intervention accounts for 4% of all vascular surgical
procedures.1,2
In the upper limb, it is more common to have emboli,
trauma or thromboangiitis obliterans than to have chronicd by Elsevier Ltd. All rights reserved.
Table 1 Patient demographics.
Demographics N (%)
Total patients 23 (100)
Mean age (range) 58 (range, 19e82)
Males 13 (56.5)
Females 10 (43.4)
Tobacco use current 5 (21.7)
e Ever 5 (21.7)
e Never 13 (56.5)
Hypertension 6 (26)
Coronary artery disease 5 (21.7)
Diabetes 11 (47.8)
ESRD 9 (39)
ESRD, end-stage renal disease.
166 F. Spinelli et al.occlusive disease.3 The increased survival of patients with
chronic renal failure has led to a considerable increase in
cases of upper limb critical ischaemia for which medical
therapy and/or endovascular treatment have their limits
and open surgery proves to be decisive.4 In the literature,
results of bypass in the upper limb are quite satisfying, with
a reported patency rate of 60e90% at 2e years.5,6 We
report our experience with arterial revascularisation of the
upper limb for treatment of chronic ischaemia using
infrabrachial bypass. Results of limb salvage and follow-up
evaluation of graft patency are analysed.
Methods
Data that were prospectively entered into the registry of
our vascular unit were analysed. We retrospectively ana-
lysed 23 patients with upper limb ischaemia treated
between 1998 and 2008 by means of bypass graft
revascularisation.
Patients treated by thrombo-embolectomy, patch
angioplasty and direct suture for acute trauma were
excluded. Indications for bypass grafts included: exercise
intolerance, rest pain and tissue loss. All patients under-
went preoperative evaluation with duplex ultrasound
mapping to locate inflow and outflow sites for arterial
revascularisation and to locate a suitable venous conduit
(saphenous and arm veins).
Patients found to have arterial calcification preventing
a correct ultrasound examination underwent preoperative
angiography. After surgical revascularisation, patients with
digital gangrene underwent debridement. This was per-
formed in the same surgical session or during the subse-
quent few days.
Postoperative treatment included low-molecular-weight
heparin (LMWH) treatment for 1 month, followed by anti-
platelet medication alone. This was treated using aspirin,
unless the patient was already on other anti-platelet
medication (i.e., clopidogrel and ticlopidine).
Postoperatively, patients were followed up at regular
intervals at 1, 3 and 6 months, and every 6 months there-
after. Graft patency was clinically evaluated by the pres-
ence of a palpable pulse and by duplex ultrasound. All data
were prospectively entered at the time of treatment into
a vascular registry (Microsoft Access and Excel, Red-
mond, WA, USA), and the registry updated periodically with
patient follow-up information. Data included demographics,
indications for surgery, co-morbid conditions, specific
operative details, complications and outcomes. A retro-
spective query of the database and chart reviews were done
for this study. Demographic and clinical characteristics of
the study population are reported as the mean, range and
percentage values. Statistical analysis was performed using
the Statistical Package for Social Sciences version 12 SPSS
(SPSS Inc., Chicago, IL, USA) statistical software. Graft
primary and secondary patency and limb salvage were
determined with the KaplaneMeier life table method.
Results
From January 1998 to January 2008, 23 bypasses were
performed on the brachial or infrabrachial artery in 23patients. The mean age was 58 years (range, 19e76 years),
with 13 male and 10 female patients (43.4%).
Concomitant diseases included: coronary artery disease
in five (21.7%) patients, hypertension in six (26%), end-stage
renal disease in nine (39%), diabetes in 11 (47.8%) and atrial
fibrillation in two patients (8.6%) (Table 1).
Indications for bypass included exercise intolerance in
four patients (17%), rest pain in nine (39%) and tissue loss in
10 (44%) (Table 2).
Five patients (22%) were scheduled for surgery after
a previous endovascular procedure.
Angioplasty without stent implantation was previously
performed on the brachial artery in one patient, on the
radial artery in three and on the ulnar artery in one; with
restenosis in three patients and occlusion in the other two
patients. The mean time from the endovascular procedure
to surgical revascularisation was 32 days (range:
26e40 days).
The aetiology of ischaemia was atherosclerosis in 17
patients (74%), complications of iatrogenic trauma in four
patients (17.4%) and chronic ischaemia after embolic
events in two patients (8.6%).
The brachial artery was used as the inflow source in 14
patients (60.8%), the axillary in two (8.6%), the radial
artery in two (8.6%), the subclavian in four (17.4%) and the
common carotid artery in one patient (4.3%).
Outflow arterial targets were: the brachial artery in
seven patients (30.4%), the radial artery in 10 (43.4%), the
ulnar artery in three (13%) and the deep palmar arch in
three patients (13%).
Biological conduits were used in all patients except one.
The conduits used were: the great saphenous vein (GSV) in
16 (70%) cases, an arm vein in three (13%), the bovine
mesenteric vein (BMV) (Hancock Jaffe Laboratories, CA,
USA) in three (13%) and polytetrafluoroethylene (PTFE)
(W.L. Gore & Associates, Inc. Flagstaff, AZ, USA) in one case
(4%) (Table 3).
Intra-operative angiography was performed with stan-
dard contrast agents in two patients (9%) with extensive
arterial calcification. Preoperative duplex ultrasound was
used in all of the other 21 patients (91%).
There were no perioperative deaths, no perioperative
cardiac complications, no postoperative wound infection or
limb loss and no incidence of postoperative pulmonary or
renal failure in this series of upper limb bypass patients.
Table 2 Indications for revascularization.
Indication N (%)
Tissue loss 10 (44)
Rest pain 9 (39)
Exercise intolerance 4 (17)
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surgical session for eight patients (35%) with digital
gangrene. For three other patients (13%), minor lesion
debridements were performed 2e3 days afterTable 3 Patient information.
Pt Sex ESRD DM Aetiology Symptoms
1 F Yes Yes Chronic Hand gangrene;
rest pain
2 F Yes Yes Chronic Fingers necrosys;
rest pain
3 F Yes Yes Chronic Ulcer phalanx
4 M No No Chronic Rest pain
5 F No No Chronic Hand rest pain
6 F No No Chronic Hand rest
pain; paresthesia
7 F No No Chronic Rest pain;
fingers paresthesia
8 M Yes No Chronic Hand rest pain
9 M No No Trauma Hand rest pain,
Fingers paresthesia
10 M No No Chronic Hand rest pain
11 M No No Trauma Exercise intolerance
12 F Yes Yes Chronic Fingers gangrene
13 F Yes No Chronic Rest pain;
fingers paresthesia
14 M Yes Yes Chronic Fingers necrosys
15 M No* Yes Chronic Hand rest pain
16 M No No Chronic Fingers rest pain;
finger necrosys
17 M No Yes Chronic Fingers paresthesia
18 M No No Trauma Fingers paresthesia;
exercise intolerance
19 F No No Trauma Fingers paresthesia;
exercise intolerance
20 M No Yes Chronic Fingers necrocis
21 M Yes Yes Chronic Purulent phalanx ulcers
22 F No Yes Chronic Distal-middle
phalanx necrotic
23 M No Yes Chronic Hand rest pain;
finger necrocis
Pt, patient; ESRD, end-stage renal disease; DM, diabetes mellitus; PTFE
patency; SP, secondary patency.revascularisation. The mean length of postoperative hos-
pitalisation was 6 days (range: 4e7 days).
The mean 34 months’ follow-up was 96% complete, with
one patient lost at 18 months (Table 3). Life table analysis
revealed a primary patency of 82.6% (standard error (SE)
10.02; 95% confidence interval (CI) (75.05e114.33)) and
a secondary patency of 91.3% (SE 8.6%; 95% CI (89.24e
120.84)). Limb salvage was 100% (Fig. 1).
During the follow-up period, four patients sustained
graft occlusion:
(1) The first patient was a 38-year-old patient with a heavy
history of drug abuse and previous arterial injection ofInflow Outflow Conduits Follow-up
Brachial Radial Saphenous 36 m PP
Radial Deep palmar
arch
Saphenous 120 m PP
Brachial Radial Saphenous 12 m PP
(dead)
Axillary Brachial Saphenous 48 m PP
Brachial Radial Saphenous 1 m PP
Occlusion
Carotid Brachial Saphenous 104 m PP
Subclavian Brachial Saphenous 36 m PP
Brachial Deep palmar
arch
Saphenous 36 m PP
Subclavian Brachial Saphenous 96 m PP
Subclavian Brachial PTFE 1 m PP
24 m SP
Axillary Brachial Saphenous 47 m. PP
Brachial Radial Saphenous 47 m PP
Brachial Radial Bovine
mesenteric vein
23 m PP
Brachial Ulnar Bovine
mesenteric vein
1 m PP
36 m SP
Brachial Radial Bovine
mesenteric vein
23 m PP
Brachial Radial Saphenous 18 m PP
Subclavian Brachial Saphenous 14 m PP
Brachial Radial Saphenous 14 m PP
Brachial Radial Saphenous 13 m PP
Radial Deep
palmar arch
Basilic vein 12 m PP
Brachial Radial Cephalic vein 12 m PP
Brachial Ulnar Cephalic vein 3 m PP
Occlusion
Brachial Ulnar Saphenous 12 m PP
, polytetrafluoroethylene; m, months (time interval); PP, primary
Figure 1 Life table of primary and secondary patency.
168 F. Spinelli et al.heroin. He had chronic upper limb ischaemia, with
severe arterial disease. He was revascularised using
GSV. Occlusion after 7 days was unresponsive to further
surgical management (Table 3, patient 5).
(2) The second patient was 76 years old with peripheral
lower limb arterial disease and ischaemic heart
disease. He was revascularised using a PTFE graft (6 mm
in diameter, 18 cm in length) due to the lack of
autogenous venous conduits and the unavailability of
BMV or other biological substitutes in our institution at
that time. Bypass occlusion after 30 days was success-
fully treated by thrombectomy. The bypass was
patent at the 24-month follow-up control (Table 3,
patient 10).
(3) The third patient was a 58-year-old man with end-stage
renal disease on chronic haemodialysis, with previous
lower limb revascularisation. He was revascularised
using a BMV prosthesis (6 mm in diameter, 12 cm in
length) due to lack of autogenous venous conduits. He
had bypass occlusion 15 days after surgery, successfully
treated by thrombectomy. The bypass was still open at
the 36-month follow-up control (Table 3, patient 14).
(4) The fourth patient was a 37-year-old woman affected
by type 1 diabetes and thrombophilia (factor V
disease). She had occlusion of a brachial to ulnar bypass
in the cephalic vein, 3 months after surgery. Before
surgery she suffered griffinclaw hand and distal
necrosis. After surgery, she had improvements in her
symptoms and in wound healing after debridement.
This improvement remained stable even after bypass
closure. The patient is regularly followed up in our
outpatient clinic, 12 months after surgery. She had
prostacyclin treatment and enjoys a better motility
status, with no further tissue loss (Table 3, patient 22).Discussion
Upper limb arterial revascularisation is not a frequently
performed operation, accounting for approximately 4% of
all vascular surgical procedures.1,2 This type of surgicaltreatment was first reported by Garret in 1965.7 Since then,
only a few other studies have reported on this treatment,
and usually on small numbers of patients (Table 4).
As noted also by Roddy et al.8 and by Hughes,9 unique
demographic differences exist between upper and lower
limb bypass populations. Patients with upper limb recon-
struction typically present at a relatively early age (mean
age of 58 in our study).
In our series of patients, the aetiology was atheroscle-
rosis in 17 patients (74%), of which nine (39%) had
concomitant end-stage renal disease. In those patients with
end-stage renal disease, distal anastomoses were per-
formed on very calcific and hard to handle ulnar and radial
arteries. Clamping of those arteries was achieved using
a distal manual clamp, or using an intra-arterial shunt, as
previously described by our group.10
Duplex ultrasound can be used in preoperative
evaluation, as previously reported in other studies, due to
the ability to locate a complete map of vessels in 89% of the
cases.11 In fact, in our series of patients we used duplex
ultrasound scan in all the patients, except for two (8.6%)
with end-stage renal disease. In those two cases, we used
arteriography with standard contrast agents due to extreme
arterial calcification, making useless the duplex ultrasound
scan. For the same reason, it was necessary to perform
a post-procedure arteriography.
The indication for surgery in our series was tissue loss for
44% of the cases. This specific indication has been more
frequent than in other reported series. Roddy et al.,8 in their
study, performed bypass grafts in patients with exertional
arm pain in 30%, with rest pain in 57% and with tissue loss in
13% of patients. Hughes et al.9 performed bypass grafts
in patients with exertional arm pain in 55%, with rest pain in
30%, and with tissue loss in 3% of patients. This difference
in indication for surgery is probably due to the fact that, in
our institution, we usually treat patients with exertional
arm pain using infusional vasoactive therapy for remission of
symptoms, while surgical treatment is used for more severe
conditions. In the presence of finger gangrene (44% of
patients), we preferred to revascularise the arm arteries
distally at the wrist level. In three cases, the distal anasto-
mosis was completed on the deep palmar arch. The ratio-
nale of this strategy is to increase collateral circulation as
close as possible to the necrotic area, with the aim of
improving wound healing. Usually arm involvement is
a consequence of extremely diffuse arterial disease.
Regarding the surgical technique, we believe that an
appropriate conduit is critical for the success of the
revascularisation. We used GSV in 16 patients. In patients
with lower limb artery disease, when GSV was previously
used for leg revascularisation, other conduits had to be
chosen. The cephalic and the basilic veins represent an
alternative. However, their use may carry some technical
difficulties because of the presence of ectasia or lesions
from previous infusional therapy in need of repair. With the
aim of having better exposure during vein harvesting, we
usually use a complete incision of the forearm. This tech-
nique is more invasive than the ‘bridge cutaneous proce-
dure’; however, we believe it may help to reduce vein
injuries during harvesting.
In three patients (13%) affected by end-stage renal
disease BMV was used, due to the absence of suitable
Table 4 Summary of the major literature references on this subject.
Author, date,
journal, country
of publication,
study type
Patient group % of gangrene Key results Comments
Spinelli F et al.
(present work),
Italy, retrospective
study
23 patients
treated between
1998 and 2008
35 Primary patency: Surgical bypass
treatment82.6% (1e3 years)
Secondary patency:
91.3% (1e3 years)
Limb salvage:100%
Hughes K et al.
(2007), J Vasc Surg,9
USA, retrospective
study
20 patients
treated between
1990 and 2003
15 Primary patency: Surgical bypass
treatment85% (1e3 years)
Secondary patency:
85% (1e3 years)
Limb salvage:100%
Chang BB et al. (2003),
J Vasc Surg,4 USA,
retrospective study
18 upper
extremities treated in
15 patients between
1992 and 2002
83 Primary patency: Surgical bypass
treatment88.8% (3e40 months)
Secondary patency: All patients
with end-stage
renal disease
88.8% (3e40 months)
Limb salvage: 88.8%
Roddy SP et al. (2001),
J Vasc Surg,8 USA,
retrospective study
61 upper extremities
treated in 56 patients
between 1986 and 1998
13 Primary patency: Surgical bypass
treatment87% (1e140 months)
Secondary patency:
98% (1e140 months)
Limb salvage:100%
Ferraresi R et al. (2006),
Circulation,12 Italy,
case-control study
1 patient Necrotic skin
lesion with soft
tissue infection and
osteomyelitis
of the distal
part of the
fourth finger
Amputation of
one finger
Endovascular
treatmentAge: 62 years
Gender: M 8-month follow-up
History: insulin-
dependent
type II diabetes
mellitus and chronic
renal failure
Cremonesi A et al.
(2009), Eur J Vasc
Endovasc Surg,13 Italy,
case-control study
1 patient painful ulcerated
ischaemic lesions
of the right
hand fingers
The 6-month angiographic
follow-up showed
focal restenosis treated
by redo balloon angioplasty
Endovascular
treatment
Bypass Surgery for Upper Limb Chronic Ischaemia 169autogenous venous conduits both in the lower and in the
upper limbs.
In another patient, we used a PTFE prosthesis. This
patient had graft thrombosis, necessitating further surgery.
Endovascular treatment is often proposed for chronic
limb ischaemia. Concerning its role in the distal upper
limbs, we should emphasise that five of the 23 patients had
a previous angioplasty without good results.
Results of endovascular treatment on the distal upper
limbs are still controversial.
There are not, at the moment, any large reported series
with a long follow-up on the endovascular treatment of
radial or ulnar arterial chronic ischaemic disease. At the
present time, there are only case reports or small case
series on endovascular treatment of this district.12,13 We
think that endovascular techniques in the subclavian
district can be useful in the treatment of proximal
segments, whereas for distal segments further investiga-
tions are needed. This is in line with a recent report
showing that endovascular treatment for cases of chronicischaemia in the upper limb was associated with more
complications as compared with an open surgical
approach.14
In patients with upper limb ischaemia, a cervico-dorsal
sympathectomy is often proposed to heal toe ulcers, alone
or in addition to a bypass. We do not have personal expe-
rience with this surgical approach. However, we believe
this could be useful when associated with revascularisation
for upper limb ischaemia. Both the traditional open
sympathectomy and minimally invasive endoscopic trans-
thoracic techniques have been used.15 However, it should
be considered that complications have been reported with
dorsal sympathectomy. The most frequent complications
are represented by Horner’s syndrome, pneumothorax and
haemothorax. More serious cardiovascular complications
have been reported as well,16 especially after bilateral
treatment. For this reason it has been suggested that
patients should be carefully questioned concerning possible
vagal symptoms before undertaking cervico-dorsal
sympathectomy.
170 F. Spinelli et al.Conclusions
In conclusion, surgery for upper limb chronic ischaemia is
an infrequent treatment. Endovascular treatment of the
upper limb distal district has not been widely reported in
the literature. Nevertheless, in our experience, endovas-
cular procedures have not produced good results. We
believe bypass surgery represents a valid treatment in this
clinical setting, both for limb salvage and for relief of
symptoms.
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